These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 16162102
1. Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation. Rodrigo E, Piñera C, de Cos MA, Sánchez B, Ruiz JC, Fernández-Fresnedo G, Palomar R, González-Cotorruelo J, Gómez-Alamillo C, de Castro SS, de Francisco AL, Arias M. Transpl Int; 2005 Oct; 18(10):1152-7. PubMed ID: 16162102 [Abstract] [Full Text] [Related]
3. Diabetes mellitus after kidney transplantation: a French multicentre observational study. Kamar N, Mariat C, Delahousse M, Dantal J, Al Najjar A, Cassuto E, Lefrançois N, Cointault O, Touchard G, Villemain F, Di Giambattista F, Benhamou PY, Diapason Study Group. Nephrol Dial Transplant; 2007 Jul; 22(7):1986-93. PubMed ID: 17400559 [Abstract] [Full Text] [Related]
8. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Shah T, Kasravi A, Huang E, Hayashi R, Young B, Cho YW, Bunnapradist S. Transplantation; 2006 Dec 27; 82(12):1673-6. PubMed ID: 17198258 [Abstract] [Full Text] [Related]
9. Risk factors for development of new-onset diabetes mellitus in pediatric renal transplant recipients: an analysis of the OPTN/UNOS database. Kuo HT, Poommipanit N, Sampaio M, Reddy P, Cho YW, Bunnapradist S. Transplantation; 2010 Feb 27; 89(4):434-9. PubMed ID: 20177345 [Abstract] [Full Text] [Related]
10. New onset diabetes mellitus incidence and risk factors in kidney transplantation: results of the observational cross-sectional study diapason. Kamar N, Mariat C, Delahousse M, Lefrançois N, Dantal J, Benhamou P. Transplant Proc; 2006 Sep 27; 38(7):2295-7. PubMed ID: 16980069 [Abstract] [Full Text] [Related]
13. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Marin M, Renoult E, Bondor CI, Kessler M. Transplant Proc; 2005 May 27; 37(4):1851-6. PubMed ID: 15919484 [Abstract] [Full Text] [Related]
18. The burden of new-onset diabetes mellitus after transplantation. Moore R, Ravindran V, Baboolal K. Clin Transplant; 2006 May 27; 20(6):755-61. PubMed ID: 17100726 [Abstract] [Full Text] [Related]
19. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation. Vincenti F, Rostaing L, DIRECT (Diabetes Incidence after REnal Transplantation: Neoral C2 monitoring versus Tacrolimus) investigators. Contemp Clin Trials; 2005 Feb 27; 26(1):17-24. PubMed ID: 15837449 [Abstract] [Full Text] [Related]
20. Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation. Pietruck F, Kribben A, Van TN, Patschan D, Herget-Rosenthal S, Janssen O, Mann K, Philipp T, Witzke O. Transpl Int; 2005 Apr 27; 18(4):483-6. PubMed ID: 15773972 [Abstract] [Full Text] [Related] Page: [Next] [New Search]